Breast Squamous Cell Carcinoma Following Breast Augmentation

Breast augmentation is widely performed, but its long-term risks remain understudied. Prior research has shown that silicone implants can cause local tissue changes, such as capsule formation. However, no prior work had resolved whether these implants could lead to rare tumor types like squamous cell carcinoma (SCC). Established knowledge includes SCC typically arising in skin or mucosal surfaces, not in breast tissue. This gap motivated investigation into whether implant-associated changes could contribute to SCC development. The patient’s history of multiple implant revisions and complications raised questions about long-term tissue effects. No prior work had resolved the link between implant use and SCC in breast tissue. This case highlights the need to track rare tumor types following cosmetic procedures.

This case report aimed to document a rare SCC of the breast following silicone implant use. The patient’s history of implant complications and subsequent tumor development raised concerns about possible implant-related carcinogenesis. The goal was to identify and describe the clinical course of this unusual cancer. The patient’s tumor was diagnosed after implant removal, suggesting a possible connection. The study sought to highlight the need for long-term monitoring of implant recipients. No prior work had resolved the progression of SCC following implant use. The patient’s metastatic spread emphasized the aggressive nature of this tumor. This case aimed to inform future clinical approaches to implant-associated malignancies.

The authors conducted a clinical case review using patient records and pathology reports. The patient’s medical history included implantation, revisions, and explantation. Pathological analysis confirmed SCC with squamous epithelization of the implant capsule. Slide review revealed benign squamous epithelium on both sides of the capsule. The tumor was staged as moderately differentiated and invasive. Radiation therapy was administered to the right breast. No adjuvant chemotherapy was used due to the rare histology. Follow-up imaging showed metastasis to the liver, lungs, and retroperitoneum.

The patient developed SCC of the breast after 21 years of silicone implant use. The tumor measured 4 cm and was moderately differentiated. Pathology showed squamous epithelization of the implant capsule. No metastasis was detected at initial diagnosis. Radiation therapy was given to the right breast. No adjuvant chemotherapy was administered. Metastasis occurred within one year to the liver, lungs, and retroperitoneum. The patient was transferred to palliative care and expired in July 2017.

The authors propose that implant-associated SCC is a rare but possible outcome of long-term implant use. The patient’s tumor developed after multiple implant revisions and explantation. The squamous epithelization of the capsule suggests a possible link to implant presence. No prior work had resolved the progression of SCC following implant use. The aggressive nature of the tumor led to rapid metastasis. The lack of adjuvant chemotherapy highlights the limited data on treating this rare histology. The case underscores the need for long-term monitoring of implant recipients. This case may inform future clinical approaches to implant-associated malignancies.